GHUCCTS

About Us

Share This

About GHUCCTS

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is a multi-institutional consortium of medical research institutions forged from a desire to promote clinical research and translational science. The members of the GHUCCTS consortium are: Georgetown University (GU), Howard University (HU), MedStar Health Research Institute (MHRI), Oak Ridge National Laboratory (ORNL), and the Washington Veteran’s Affairs Medical Center (VAMC).

Through multiple partnerships and collaborations among the member institutions, GHUCCTS is transforming clinical research and translational science in order to bring new scientific advances to health care. 

GHUCCTS was founded on five basic principles that have been endorsed by each of the member institutions. These serve to identify the overall purpose of the consortium, as well as key aspects of its research activities, governance, and focus. These principles form the foundation of the consortium itself, as well as the GHUCCTS programs of research and education.


GHUCCTS Founding Principles

  1. The primary goal of GHUCCTS is to improve the infrastructure that supports high quality multidisciplinary clinical and translational research, both via inter-institutional collaborations across all GHUCCTS institutions as well as multicenter clinical trials across the national CTSA consortium, with increasing levels of speed and efficiency, and to develop innovative informatics methods to speed and enhance translation.

  2. We continue to develop GHUCCTS as a model of inter-institutional collaboration that leverages the strengths and attributes of its diverse participating institutions

  3. Leverage our location, expertise and the co-leadership of a minority-serving institution to design and implement research that will have a high impact on underserved populations, including minorities, people with disabilities, and elderly populations.

  4. Design and disseminate vibrant and innovative educational programs at multiple levels (undergraduate, medical school, graduate, study coordinators, research nurses, and junior faculty) that promote team science and provides the highest quality of career development training for the clinical and translational investigators of the future.

  5. Draw from and contribute to the collective effort of the National CTSA consortium to advance GHUCCTS, the National Center for Advancing Translational Science (NCATS), and the CTSA consortium.
Related News

GHUCCTS announces 2022 KL2 Scholar Dr. Christina Marea

Aug 12, 2022

After our 12th highly competitive application cycle, unfortunately, delayed due to COVID-related uncertainties, the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is pleased to announce the appointment of Christina X. Marea, PhD, MA, MSN, FACNM as our newest KL2 Scholar.

Request for Applications: 2022 KL2 Scholars Program

Mar 10, 2022

The GHUCCTS KL2 Scholars Program is now accepting applications for our 2022 funding cycle. Applicants must have a full-time faculty or equivalent appointment at a GHUCCTS institution (Georgetown University, Howard University, or MedStar Health) at the time of award activation.

Request for Applications: 2022-2023 TL1 Translational Biomedical Science Program

Mar 07, 2022

The GHUCCTS TL1 Translational Biomedical Science (TBS) Program is now accepting applications for our 2022-2023 funding cycle. Applicants should be predoctoral students who have completed their qualifying exams in PhD programs at Howard or Georgetown Universities or Postdoctoral fellows who have a primary appointment at Georgetown or Howard Universities, a MedStar Institution, or the Washington DC VAMC.

Close